Forte Biosciences (FBRX) Non Operating Investment Income (2016 - 2020)
Historic Non Operating Investment Income for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$10000.0.
- Forte Biosciences' Non Operating Investment Income fell 12439.02% to -$10000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was -$18000.0, marking a year-over-year decrease of 11428.57%. This contributed to the annual value of $33000.0 for FY2019, which is 20000.0% up from last year.
- Per Forte Biosciences' latest filing, its Non Operating Investment Income stood at -$10000.0 for Q1 2020, which was down 12439.02% from -$33000.0 recorded in Q4 2019.
- In the past 5 years, Forte Biosciences' Non Operating Investment Income registered a high of $54000.0 during Q1 2016, and its lowest value of -$74000.0 during Q1 2018.
- Its 5-year average for Non Operating Investment Income is $3866.7, with a median of -$1000.0 in 2017.
- Data for Forte Biosciences' Non Operating Investment Income shows a peak YoY increase of 100000.0% (in 2018) and a maximum YoY decrease of 730000.0% (in 2018) over the last 5 years.
- Over the past 5 years, Forte Biosciences' Non Operating Investment Income (Quarter) stood at -$9000.0 in 2016, then tumbled by 244.44% to -$31000.0 in 2017, then soared by 200.0% to $31000.0 in 2018, then plummeted by 206.45% to -$33000.0 in 2019, then skyrocketed by 69.7% to -$10000.0 in 2020.
- Its Non Operating Investment Income stands at -$10000.0 for Q1 2020, versus -$33000.0 for Q4 2019 and -$13000.0 for Q3 2019.